- Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity2007 | Publication without faculty affiliation
- Development of LC-MS method for the analysis of novel iron chelator - Dp44mTPublication without faculty affiliation
- HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents2009 | Central Library of Charles University
- Development of HPLC method for determination of a novel anticancer agent - Dp44mT - in rabbit plasmaPublication without faculty affiliation
- Development of HPLC methods for purity and stability evaluation of potential anti-cancer agentsPublication without faculty affiliation
- HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents2009 | Faculty of Pharmacy in Hradec Králové
- Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents2015 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity2007 | Faculty of Pharmacy in Hradec Králové
- Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs2014 | Faculty of Pharmacy in Hradec Králové
- Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells2022 | First Faculty of Medicine
